Peel Hunt reaffirmed their buy rating on shares of Eco Animal Health Group (LON:EAH) in a report published on Thursday morning.
Eco Animal Health Group stock traded down GBX 2 ($0.03) during trading hours on Thursday, reaching GBX 438 ($5.72). The company had a trading volume of 23,823 shares, compared to its average volume of 39,512. Eco Animal Health Group has a 12-month low of GBX 485 ($6.34) and a 12-month high of GBX 680 ($8.89).
About Eco Animal Health Group
ECO Animal Health Group plc develops and markets pharmaceutical products for animals worldwide. The company offers Aivlosin, a macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry. It also provides generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.
See Also: Fundamental Analysis and Choosing Stocks
Receive News & Ratings for Eco Animal Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eco Animal Health Group and related companies with MarketBeat.com's FREE daily email newsletter.